Dahuang Zhechong pill attenuates CCl4‐induced rat liver fibrosis via the PI3K‐Akt signaling pathway

Yu Gan Long reduces rat liver fibrosis by blocking TGF-β1/Smad pathway and modulating the immunity

(2018) Yu Xia et al.   BIOMEDICINE & PHARMACOTHERAPY

Protective effects of Liuweiwuling tablets on carbon tetrachloride-induced hepatic fibrosis in rats

(2018) Huimin Liu et al.   BMC Complementary and Alternative Medicine

Asiatic acid attenuates CCl 4 -induced liver fibrosis in rats by regulating the PI3K/AKT/mTOR and Bcl-2/Bax signaling pathways

(2018) Liwen Wei et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective

(2018) Mohammad Farzaei et al.   Nutrients

The Pharmacological Targets and Clinical Evidence of Natural Products With Anti-hepatic Inflammatory Properties

(2018) Jinghua Peng   Frontiers in Pharmacology

Fuzheng Huayu capsule as an adjuvant treatment for HBV-related cirrhosis: A systematic review and meta-analysis

(2017) Tao Wang et al.   PHYTOTHERAPY RESEARCH

TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis

(2016) Fengyun Xu et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Effect of Dahuang zhechong formula on liver fibrosis in patients with chronic hepatitis B: A meta-analysis

(2015) Feifei Wei et al.   COMPLEMENTARY THERAPIES IN MEDICINE

Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects

(2015) Ming Hong et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Targeting PI3 kinase in cancer

(2015) Todd M. Bauer et al.   PHARMACOLOGY & THERAPEUTICS

A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition

(2015) Wenting Xu et al.   Cell Adhesion & Migration

Traditional Chinese Medicine (TCM) for fibrotic liver disease: Hope and hype

(2014) Lijun Zhang et al.   JOURNAL OF HEPATOLOGY

PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes

(2012) Ipsita Pal et al.   ACTA PHARMACOLOGICA SINICA

PI3K-PKB/Akt Pathway

(2012) B. A. Hemmings et al.   Cold Spring Harbor Perspectives in Biology

Evaluation of the liver protection and toxicity of Da-Huang-Zhe-Chong pill in rats

(2011) Xiao-yan Xing et al.   PHARMACEUTICAL BIOLOGY

Management of liver cirrhosis between primary care and specialists

(2011) Ignazio Grattagliano   WORLD JOURNAL OF GASTROENTEROLOGY

Effects of dahuangzhechong pills on cytokines and mitogen activated protein kinase activation in rats with hepatic fibrosis

(2010) Hong Bing Cai et al.   JOURNAL OF ETHNOPHARMACOLOGY

Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis

(2009) Gakuhei Son et al.   HEPATOLOGY